Industry news

• A biotechnological substances production line has been opened at Medsyntez plant

  23 November 2022 GxPnews

  A new workshop for the production of biotechnological substances for women’s reproductive health has opened at Medsintez plant in Novouralsk, Sverdlovsk Region, according to the official website of the Plenipotentiary Representative of the President of the Russian Federation in the Ural Federal District.

• 4,000 jobs will be created at the new pharmaceutical complex in Solnechnogorsk

  23 November 2022 GxPnews

  The Moscow Architecture Department supported the architectural and urban planning solutions of the pharmaceutical production and logistics complex planned in Esipovo Industrial Park in the Solnechnogorsk municipal district. This is reported on the website of the Committee for Architecture and Urban Planning of the Moscow region.

• “Molecular sponge” for targeted drug delivery

  22 November 2022 Marchmont Innovation News

  Researchers at the Southern Federal University (SFedU) in Rostov-on-Don have developed novel nanodimensional containers for storage, target delivery and controllable dosing of drugs.

• New technology aimed at stopping degenerative cerebral dysfunctions

  22 November 2022 Marchmont Innovation News

  Researchers in St. Petersburg have come up with what they say is an “effectual” drug candidate to treat Alzheimer’s related degenerative cerebral dysfunctions. The St. Petersburg Institute of Bioregulation and Gerontology and the Pavlov Institute of Physiology are behind the research effort.

• The Ministry of Health has registered a domestic vaccine against smallpox

  21 November 2022 GxPnews

  Orthopoxvac, a domestically developed vaccine against smallpox, has been registered by the Ministry of Health of Russia. The information on the fact was published in the State Register of Medicines.

• Russia’s market of medical products has almost doubled in four years

  21 November 2022 GxPnews

  More than 80% of medicines from the Vital and Essential Drugs list ones are produced domestically, and more than 30% of medical devices are Russian-made, said Yevgeny Kamkin, Deputy Minister of Health of the Russian Federation.

• Four new pharmaceutical enterprises will appear in Moscow as a result of offset contracts

  18 November 2022 GxPnews

  Moscow plans to conclude four state contracts with reciprocal investment obligations (offset contracts) for the supply of drugs. Potential investors will participate in electronic bidding. The orders to that effect have been signed by Sergei Sobyanin. This is reported on the official website of the mayor of Moscow.

• The ASI and the Circle of Kindness will improve the organization of assistance to seriously ill children

  18 November 2022 GxPnews

  Svetlana Chupsheva, Director General of the Agency for Strategic Initiatives (ASI), and Aleksander Tkachenko, Chairman of the Board of the Circle of Kindness Foundation for the Support of Children with Severe and Rare Diseases, signed an agreement aimed at improving the organization of assistance to seriously ill children in Russia. This was reported in the press service of the ASI.

• Patients want more info about clinical trials. Here’s how biopharma can help

  17 November 2022 FiercePharma

  Enrolling clinical trials quickly can make a big difference in cutting the time it takes for patients to access new therapies and enabling sponsors to leapfrog rivals in the race to market. But while the industry has yet to address a fundamental barrier to enrollment—low patient knowledge of clinical trials—the good news is that patients are interested in learning more.

• RBC: Russia is facing increased demand for insulin drugs this autumn

  17 November 2022 GxPnews

  In autumn, the demand for insulin drugs in Russian pharmacies increased again, according to RBC. Analysts of the DSM Group marketing agency found out that  97,700 packages of the hypoglycemic drugs were sold in September (in monetary terms, it is 147.7 million rubles), which is a 15% growth in packages and 18% in monetary terms compared to the previous month.